# Stryker and CMR Surgical announce strategic alliance for Versius robotic surgery

Stryker has made a $400 million preferred equity investment in CMR Surgical, with an exclusive option to acquire the company. Stryker will serve as the exclusive U.S. sales agent for CMR Surgical's Versius robotic surgery portfolio.

- Type: Partnership
- Announced: 2026-10-12
- Where: United States
- Value: $400.0M
- Status: announced
- Products: Versius Surgical Robotic portfolio, soft-tissue robotics
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Stryker](https://endata.com/companies/15355.md) (investor)
- [CMR Surgical](https://endata.com/companies/15356.md) (partner)

## Sources

- [stryker.com](https://www.stryker.com/ir/en/about/news/2026/stryker-cmr-surgical-announce-strategic-alliance-advance-robotic-assisted-surgery.html), 2026-10-12: "Stryker will make an approximately $400 million (£300 million) preferred equity investment in CMR Surgical to support future innovation and global commercialization of the Versius portfolio, subject to customary closing conditions."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.